Species predicted to react based on 100% sequence homology:Bovine, Dog, Horse
Specificity / Sensitivity
HEXIM1 Antibody recognizes endogenous levels of total HEXIM1 protein.
Source / Purification
Polyclonal antibodies are produced by immunizing animals with a synthetic peptide corresponding to residues near the amino terminus of human HEXIM1 protein. Antibodies are purified by protein A and peptide affinity chromatography.
Background
Hexamethylene bisacetamide-induced protein 1 (HEXIM1) was originally identified in vascular smooth muscle cells as a protein that is upregulated upon treatment with the differentiating agent hexamethylene bisacetamide (1). HEXIM1 binds to 7SK RNA, a highly abundant non-coding RNA, and together act as a potent inhibitor of positive transcription elongation b (P-TEFb) (2,3). P-TEFb phosphorylates the C-terminal domain of the largest subunit of RNA polymerase II and is an important regulator of transcription elongation (4-8). 7SK RNA-bound HEXIM1 interacts with the Cyclin T1 subunit of P-TEFb, sequestering it in an inactive form leading to transcription inhibition (2,3). The regulation of the relative ratio of inactive to active P-TEFb in the cell by HEXIM1/7SK RNA is thought to play a critical role in regulation of a wide range of cellular gene expression programs such as estrogen and glucocorticoid receptor regulated genes (9-12).